ADVISORY/Drug Marketing Gets Personal Forrester Research Media Alert.Business/Technology Editors & Health/Medical Writers ADVISORY ... for Monday Monday: see week. (Oct. 21) --(BUSINESS WIRE)
What: Forrester((NASDAQ:FORR) Healthcare Summit
Drug firms, payers, and providers alike have a
lot riding on influencing consumers' drug
choices and use. A better understanding of
individual consumers' needs and preferences
creates a clear path to greater influence. But
personal healthcare data is a controversial
commodity today, with privacy flare-ups
regularly making news. Forrester's Healthcare
Summit will outline new insights and best
practices in using consumer data to gain
consumer intimacy, bolster product sales, and
better target new treatments.
Key takeaways:
-- What data practices appropriately balance
personalization with privacy to make drug
marketing more effective?
-- What new technologies should your
organization implement to unlock the value
of consumer data?
-- What are the limits of consumer drug
marketing? And which firms are successfully
using it to bolster product sales?
Who: Industry speakers include:
-- John N. Hallick, President and CEO, CPM
Marketing Group
-- Roger C. Holstein, CEO, WebMD Health,
Member of the Office of the President,
WebMD Corp.
-- Eric S. Elliott, President, Tel-Drug and
CIGNA Pharmacy Management Organization,
CIGNA HealthCare
-- Jeffrey M. Kern, Director of
Gastroenterology, TAP Pharmaceuticals
When: October 21-22, 2002
Where: Hotel Inter-Continental Miami
100 Chopin Plaza
Miami, FL 33131
For complete Event information please visit:
http://www.forrester.com/Events/Overview/0,5158,476,00.html
Media: To request interviews and register for the
Event, please provide your complete
contact information to press@forrester.com or
contact:
Mariko Zapf
Public Relations
mzapf@forrester.com
+1 617/613-6255
|
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion